Variant report
Variant | nsv521792 |
---|---|
Chromosome Location | chr13:66691810-66713678 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34876584 | chr13:66711623-66711624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs112623937 | chr13:66711721-66711722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs74471382 | chr13:66711725-66711726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543906005 | chr13:66711768-66711769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556357209 | chr13:66711782-66711783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560648934 | chr13:66711893-66711894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529699405 | chr13:66711947-66711948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554381064 | chr13:66711962-66711963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566261043 | chr13:66712039-66712040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs115121621 | chr13:66712068-66712069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs117001252 | chr13:66712092-66712093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188173588 | chr13:66712099-66712100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146864665 | chr13:66712100-66712101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs369362166 | chr13:66712112-66712113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs181948154 | chr13:66712180-66712181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs139757664 | chr13:66712204-66712205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs371416300 | chr13:66712214-66712215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs114510487 | chr13:66712242-66712243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146419040 | chr13:66712249-66712250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554160212 | chr13:66712269-66712270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577131021 | chr13:66712282-66712283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116718572 | chr13:66712302-66712303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs556393888 | chr13:66712304-66712305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs79684650 | chr13:66712310-66712311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542012438 | chr13:66712334-66712335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs77637249 | chr13:66712366-66712367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs543132822 | chr13:66712421-66712422 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574454349 | chr13:66712447-66712448 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539921384 | chr13:66712448-66712449 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs144112974 | chr13:66712472-66712473 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187469084 | chr13:66712474-66712475 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs17489276 | chr13:66712478-66712479 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs552500289 | chr13:66712523-66712524 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562768184 | chr13:66712528-66712529 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140738093 | chr13:66712556-66712557 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs548389088 | chr13:66712574-66712575 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs543799290 | chr13:66712600-66712601 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs568487460 | chr13:66712619-66712620 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539501789 | chr13:66712629-66712630 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs376357334 | chr13:66712706-66712707 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs4884651 | chr13:66712732-66712733 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs374212562 | chr13:66712738-66712739 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs570828478 | chr13:66712742-66712743 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs115260715 | chr13:66712751-66712752 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556483013 | chr13:66712772-66712773 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9529023 | chr13:66712790-66712791 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs4884652 | chr13:66712815-66712816 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs560261315 | chr13:66712817-66712818 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7329287 | chr13:66712828-66712829 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs572511601 | chr13:66712850-66712851 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Intellectual disability | 21811512 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 20877625 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:66711600-66712400 | Enhancers | Primary B cells from cord blood | blood |
2 | chr13:66711600-66712400 | Enhancers | GM12878-XiMat | blood |
3 | chr13:66712200-66715600 | Enhancers | Primary B cells from peripheral blood | blood |
4 | chr13:66712400-66712600 | Flanking Active TSS | Primary B cells from cord blood | blood |
5 | chr13:66712400-66713400 | Weak transcription | GM12878-XiMat | blood |
6 | chr13:66712600-66712800 | Enhancers | Primary B cells from cord blood | blood |
7 | chr13:66712800-66713000 | Flanking Active TSS | Primary B cells from cord blood | blood |
8 | chr13:66712800-66713200 | Enhancers | Gastric | stomach |
9 | chr13:66712800-66714200 | Enhancers | HepG2 | liver |
10 | chr13:66713000-66714600 | Enhancers | Hela-S3 | cervix |
11 | chr13:66713000-66715400 | Enhancers | Primary B cells from cord blood | blood |
12 | chr13:66713200-66714400 | Weak transcription | Gastric | stomach |
13 | chr13:66713400-66714600 | Enhancers | GM12878-XiMat | blood |